Axsome Therapeutics
AXSM
AXSM
179 hedge funds and large institutions have $1.95B invested in Axsome Therapeutics in 2020 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 66 increasing their positions, 59 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.29% less ownership
Funds ownership: 64.51% → 64.22% (-0.29%)
10% less call options, than puts
Call options by funds: $49.9M | Put options by funds: $55.3M
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
179
Holding in Top 10
4
Calls
$49.9M
Puts
$55.3M
Top Buyers
| 1 | +$40.1M | |
| 2 | +$29.3M | |
| 3 | +$27.8M | |
| 4 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
+$11.9M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$4.52M |
Top Sellers
| 1 | -$30.9M | |
| 2 | -$18.2M | |
| 3 | -$14.7M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$14.3M |
| 5 |
Goldman Sachs
New York
|
-$12.4M |